Stocks making the biggest moves in the premarket: Tesla, WeWork, Alibaba and more

Stocks making the biggest moves in the premarket: Tesla, WeWork, Alibaba and more


Dow futures rise slightly as Wall Street tries to build on its best week since June

VIDEO1:1901:19
Dow futures rise slightly as Wall Street tries to build on its best week since June
Morning Report

Take a look at some of the biggest movers in the premarket:

Tesla (TSLA) – Tesla fell 2.5% in the premarket after cutting Model 3 and Model Y prices in China by up to 9%. The price cuts come amid signs of softening demand in China. Chinese EV makers are also seeing their shares under pressure, with Nio (NIO), down 10.4%, XPeng (XPEV), losing 11.3% and Li Auto (LI), falling 10.3%.

WeWork (WE) – The office-sharing company’s stock jumped 3.8% in the premarket after Cantor Fitzgerald rated it “overweight” in new coverage. Cantor notes that $2.7 billion in expenses have already been removed through cost cuts and optimizing the company’s real estate portfolio.

Alibaba (BABA) – Alibaba tumbled 12.3% in premarket trading after the release of weaker-than-expected China GDP data. The Chinese e-commerce giant saw the price of its US ADRs dip below their 2014 IPO level of $68 per share.

China Tech Stocks – China-based tech stocks are under pressure after President Xi secured a third leadership term, leading to speculation of a continued crackdown on the country’s tech sector. Among shares that trade in the U.S., JD.com (JD) tumbled 15.9% in the premarket, Baidu (BIDU) slid 12.7% and Tencent Music (TME) fell 11%.

Royal Philips (PHG) – Royal Philips fell 2.2% in premarket action after reporting a bigger-than-expected loss, with the Dutch medical equipment maker also saying it would be cutting 4,000 jobs, or about 5% of its workforce. Its results were hurt by supply chain issues as well as a sizeable recall of a sleep apnea device.

Myovant Sciences (MYOV) – Myovant jumped 8.1% in the premarket after the drugmaker agreed to be bought by a subsidiary of majority shareholder Sumitomo Pharma for $27 per share. That price is 10% above a prior offer by Sumitomo, which already owns 52% of Myovant.

ServiceNow (NOW) – ServiceNow added 2.5% in premarket trading after Guggenheim upgraded the stock to “buy” from “neutral.” The firm says the digital workflow software company has “admirable” profit margins and a dependable customer base.

Medtronic (MDT) – The medical equipment maker announced plans to spin off its patient monitoring and respiratory interventions unit into a separate company. Medtronic added 1% in premarket trading.

Williams-Sonoma (WSM) – The housewares retailer’s stock was downgraded to “underperform” from “hold” at Jefferies, which sees the shares underperforming under a more difficult economic environment. Williams-Sonoma fell 2.5% in premarket action.



Source

China didn’t grab many headlines at Davos, but it’s the elephant in the room
Finance

China didn’t grab many headlines at Davos, but it’s the elephant in the room

Davos 2026 China didn’t grab many headlines at Davos, but it’s the elephant in the room Published Sun, Jan 25 20267:04 PM ESTUpdated 56 Min Ago Evelyn Cheng@in/evelyn-cheng-53b23624@chengevelyn WATCH LIVE Source

Read More
Energy stocks to watch as major winter storm rips through the U.S.
Finance

Energy stocks to watch as major winter storm rips through the U.S.

Winter storm Fern is projected to have a wide-ranging impact on energy and power production. Here are a few stocks and energy related industry groups to watch around this and future storms. Natural gas producers The price move in natural gas has been profound. A 70% jump in the commodity in fewer than two weeks is stuff […]

Read More
Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more
Finance

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more

Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won’t hurt the company as much as some suspect. The firm’s $100 price target suggests 29% upside ahead. Bausch Health — The pharmaceutical stock […]

Read More